Biological Products: Cellular Therapy and FDA Approved Products

Stem Cell Rev Rep. 2019 Apr;15(2):166-175. doi: 10.1007/s12015-018-9866-1.


The pace of advances in the world of science have created new opportunities and insights that give us new and more understanding of our nature and environment. Among the different fields of science, new medical sciences have drawn a great deal of attention among medical science researchers and the society. The hope for finding treatments for incurable diseases and further improvement of man's health is growing thanks to new medical technologies. Among the novel medical fields that have been extensively covered by medical and academic societies are cell therapy and gene therapy that are categorized under regenerative medicine. The present paper is an attempt to introduce the prospect of a curative cell-based therapy and new cellular and gene therapy drugs that have been recently approved by FDA (food and drug administration). Cellular and gene therapy are two very close fields of regenerative medicine and sciences which their targets and applications can be discussed together. What adds to the importance of this new field of science is the possibility to translate the hope for treatment of incurable diseases into actual treatments. What follows delves deeper into this new field of science and the drugs.

Keywords: Applications; Approved drugs; Cellular therapy; Gene therapy; Stem cell.

Publication types

  • Review

MeSH terms

  • Biological Products / therapeutic use*
  • Cell- and Tissue-Based Therapy / methods*
  • Genetic Diseases, Inborn / genetics
  • Genetic Diseases, Inborn / immunology
  • Genetic Diseases, Inborn / therapy*
  • Genetic Therapy / methods*
  • Humans
  • Regenerative Medicine / trends*
  • United States
  • United States Food and Drug Administration


  • Biological Products